Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

Henk van der Poel

doi:10.1016/j.eururo.2019.07.021

Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

Henk van der Poel

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	705-706
Number of pages	2
Journal	European Urology
Volume	76
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2019.07.021
Publication status	Published - Nov 2019
Externally published	Yes

Access to Document

10.1016/j.eururo.2019.07.021

Cite this

@article{decff355543641ac9202730e5a5b0a6e,

title = "Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial",

author = "{van der Poel}, Henk",

year = "2019",

month = nov,

doi = "10.1016/j.eururo.2019.07.021",

language = "English",

volume = "76",

pages = "705--706",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial. / van der Poel, Henk.
In: European Urology, Vol. 76, No. 5, 11.2019, p. 705-706.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Re

T2 - Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

AU - van der Poel, Henk

PY - 2019/11

Y1 - 2019/11

UR - http://www.scopus.com/inward/record.url?scp=85069730164&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2019.07.021

DO - 10.1016/j.eururo.2019.07.021

M3 - Comment/Letter to the editor

C2 - 31358379

SN - 0302-2838

VL - 76

SP - 705

EP - 706

JO - European Urology

JF - European Urology

IS - 5

ER -

Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial

Access to Document

Other files and links

Cite this